![Camilla Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Camilla Hansen
Director/Board Member at
LimmaTech Biologics AG
Profile
Camilla Petrycer Hansen is currently Director at Hoba Therapeutics ApS, Director at LimmaTech Biologics AG since 2023, and Partner at Novo Holdings Ltd. starting in 2025.
Former positions include Chairman at Aloop Therapeutics ApS, Director at Centauri Therapeutics Ltd., and Principal at Novo Seeds from 2021 to 2025.
Education includes graduate and doctorate degrees from the University of Copenhagen.
Camilla Hansen active positions
| Companies | Position | Start |
|---|---|---|
Novo Holdings Ltd.
 Novo Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Corporate Officer/Principal | 2024-12-31 |
Hoba Therapeutics ApS
 Hoba Therapeutics ApS BiotechnologyHealth Technology Engages in research and development of therapeutics for pain, hearing loss and sensory neuron disorders | Director/Board Member | - |
LimmaTech Biologics AG
 LimmaTech Biologics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops vaccines for prevention of life-threatening diseases | Director/Board Member | 2023-10-08 |
Former positions of Camilla Hansen
| Companies | Position | End |
|---|---|---|
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds invests in companies located in Europe and the United States. The fund targets companies operating in the fields of life science and healthcare technology sectors. It provides financing for seed and early stage capital requirement. | Private Equity Analyst | 2020-11-30 |
Aloop Therapeutics ApS
 Aloop Therapeutics ApS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Chairman | - |
Centauri Therapeutics Ltd.
 Centauri Therapeutics Ltd. BiotechnologyHealth Technology Operates as an immunotherapy biotechnology company that engages in discovery and development of novel molecules targeting life threatening diseases | Director/Board Member | - |
Training of Camilla Hansen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
25
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds invests in companies located in Europe and the United States. The fund targets companies operating in the fields of life science and healthcare technology sectors. It provides financing for seed and early stage capital requirement. | Finance |
Novo Holdings Ltd.
Novo Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Centauri Therapeutics Ltd.
Centauri Therapeutics Ltd. BiotechnologyHealth Technology Operates as an immunotherapy biotechnology company that engages in discovery and development of novel molecules targeting life threatening diseases | Health Technology |
Hoba Therapeutics ApS
Hoba Therapeutics ApS BiotechnologyHealth Technology Engages in research and development of therapeutics for pain, hearing loss and sensory neuron disorders | Health Technology |
LimmaTech Biologics AG
LimmaTech Biologics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops vaccines for prevention of life-threatening diseases | Health Technology |
Aloop Therapeutics ApS
Aloop Therapeutics ApS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
- Stock Market
- Insiders
- Camilla Hansen
